StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery." title="" class="btn" data-container="body" data-html="true" data-id="256176" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="StemSight - Vision Unlimited"> 1,331
Activities
Technologies
Entity types
Location
Tampere, Finland
Tampere
Finland
Employees
Scale: 2-10
Estimated: 16
Engaged corporates
1Added in Motherbase
1 month agoCuring blindness with regenerative cell therapies.
StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery.
StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Other 31 Oct 2024 | |